Applied Clinical Trials-09-01-2012

During the annual ASCO meeting in June, the US Chinese Anti-Cancer Association (USCACA) held its fourth annual meeting to discuss the emerging role of China in global clinical development of novel anti-cancer drugs.

Tufts CSDD

Moving into electronic methods to facilitate laboratory collections for clinical trials.

The use of flow cytometry can add value in Phase I studies.

Conversion from paper to ePRO for an instrument designed to assess diabetes' impact on quality of life.

Even though thousands of clinical trials are listed on public websites, and sponsors are posting results from more key studies, consumer advocates continue to press for broader public disclosure of information on research involving human subjects.

Practical approaches to new challenges and opportunities in inflammation trials.

S

An entire section of Horizon 2020 is devoted to health, demographic change, and well-being.

Regulators must stop approving so many new drugs of very limited therapeutic value, and the European Medicines Agency (EMA) and other regulatory bodies should be fully funded by public money rather than relying on industry-generated user fees, according to an article published by the British Medical Journal.

S

Demonstrating biosimilarity is highly dependent on the unique characteristics of the product.

Medidata

Illuminating the advantages of multiplexing for advanced biomarker testing.

Biomarkers help researchers develop new drugs faster and more effectively.

From tactical to strategic: tracking the evolution of global clinical supply chain management.

Industry news focusing on the people and organizations who work in the clinical trials profession.

eClinical: The Use of ePRO in Diabetes Studies CRO/Sponsor: Managing the Global Supply Chain Also in this issue: Clinical Trial Funding CRO Market Size Biosimilar Development